Delivery Order SPE2DB20D2104-SPE2DB25FMNSX

Award Date 4/16/25
Potential Completion Date 4/17/25
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,609.95 firm fixed-price delivery order is for the supply of 4,568,156,034 units of the medication Clomid 50 mg tablet, with an ultimate completion date of May 7, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,528.40 delivery order contract is for the provision of 4,568,175,075 units of the medication Clomid 50 mg tablets. The contract is a firm fixed-price, non-set-aside award with a performance period through May 8, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This federal contract award, with ID SPE2DB24D1104|SPE2DB25FYAC0, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $22,855.93 firm fixed-price delivery order contract is for the supply of 4,567,984,802 units of the medication Clomid 50 mg tablets. The contract has an ultimate completion date of April 22, 2025 and is not set aside. AmerisourceBergen Drug Corp, the prime contractor, holds a significant $999,999,999.00...
This federal contract award, with ID SPE2DX15D7062|SPE2DX25FJFSH, was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,152.70 firm fixed-price delivery order is for the supply of 4,568,194,156 units of the medication Clomid 50 mg tablets. The contract has an ultimate completion date of June 6, 2025. AmerisourceBergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award, with ID SPE2DB25D3110|SPE2DB25FTDCX, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,226.60 firm-fixed-price delivery order is for the supply of 4,568,014,272 units of the medication Clomid 50 mg tablets. The contract has an ultimate completion date of April 24, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,310.33, is for the delivery of Clomid 50 mg tablets. It is a firm fixed-price delivery order contract that runs through February 10, 2025. The contract does not have a set-aside designation, indicating it was open to all eligible vendors. AmerisourceBergen has a significant Indefinite Delivery...
This federal contract award, valued at $2,702.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,957,353 units of the medication Clomid 50 mg tablets, with an ultimate completion date of April 18, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of pharmaceutical products, including Clomid 50 mg tablets. The $1,426.99 fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical and medical supplies to support military healthcare programs globally. The contract does...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,892.71, is a delivery order for Clomid 50 mg tablets with an ultimate completion date of December 3, 2024. The contract is a firm fixed-price arrangement, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of Clomid 50 mg tablets to the Defense Logistics Agency (DLA). The $2,094.49 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on April 25, 2024, with a completion date of April 26, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMNSX
    Delivery Order

This federal contract award, SPE2DB20D2104|SPE2DB25FMNSX, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,746.03 firm fixed-price delivery order is for the supply of 4,567,943,515 units of the pharmaceutical product Clomid 50 mg tablets. This contract has no set-aside designation, indicating open competition.

AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 7/16/25, 11:49 AM